In the last trading session, 4.14 million shares of the Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) were traded, and its beta was 0.95. Most recently the company’s share price was $10.97, and it changed around $0.12 or 1.11% from the last close, which brings the market valuation of the company to $1.66B. IRWD currently trades at a discount to its 52-week high of $12.66, offering almost -15.41% off that amount. The share price’s 52-week low was $9.73, which indicates that the current value has risen by an impressive 11.3% since then. We note from Ironwood Pharmaceuticals Inc.’s average daily trading volume that its 3-month average coming to 2.41 million.
Ironwood Pharmaceuticals Inc. stock received a consensus recommendation rating of an Overweight, based on a mean score of 2.20. If we narrow it down even further, the data shows that 0 out of 3 analysts rate the stock as a Sell; another 1 rate it as Overweight. Among the rest, 1 recommended IRWD as a Hold, whereas 1 deemed it a Buy, and 0 rated it as Underweight. Ironwood Pharmaceuticals Inc. is expected to report earnings per share of $0.25 for the current quarter.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) trade information
Instantly IRWD has showed a green trend with a performance of 1.11% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 11.34 on Tuesday, 05/23/23 increased the stock’s daily price by 3.26%. The company’s shares are currently down -11.46% year-to-date, but still up 8.61% over the last five days. On the other hand, Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD) is 3.78% up in the 30-day period.
The consensus price target as assigned by Wall Street analysts is $14.33, which translates to bulls needing to increase their stock price by 23.45% from its current value. Analyst projections state that IRWD is forecast to be at a low of $9.00 and a high of $19.00. In order for the stock price to hit the forecast high, the stock would need to plunge -73.2% from its current level, while the stock would need to crash 17.96% from its current level to reach the projected low.
Ironwood Pharmaceuticals Inc. (IRWD) estimates and forecasts
Ironwood Pharmaceuticals Inc. share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -5.76 percent over the past six months and at a 10.42% annual growth rate that is well below the industry average of 13.30%. The year-over-year growth rate is expected to be 4.20%, up from the previous year.
Consensus estimates provided by 3 financial analysts predict the company will bring in an average of $103.71 million in revenue for the current quarter. 3 analysts expect Ironwood Pharmaceuticals Inc. to make $110.23 million in revenue for the quarter ending Sep 2023. The company’s sales for the same quarters a year ago were $97.23 million and $109.36 million respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 6.70%. Forecasts for the next quarter put sales growth at 0.80%.
Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 35.80%.
Ironwood Pharmaceuticals Inc.’s next quarterly earnings report is expected to be released around August 02 and August 07.
Ironwood Pharmaceuticals Inc. (NASDAQ:IRWD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.82% of Ironwood Pharmaceuticals Inc. shares, and 112.77% of them are in the hands of institutional investors. The stock currently has a share float of 114.86%. Ironwood Pharmaceuticals Inc. stock is held by 361 institutions, with Blackrock Inc. being the largest institutional investor. By Mar 30, 2023, it held 16.30% of the shares, which is about 25.32 million shares worth $266.34 million.
Sarissa Capital Management, LP, with 10.55% or 16.39 million shares worth $172.42 million as of Mar 30, 2023, holds the second largest percentage of outstanding shares.
Vanguard Specialized-Health Care Fund and iShares Core S&P Smallcap ETF were the top two Mutual Funds as of Jan 30, 2023. The former held 10.9 million shares worth $125.59 million, making up 7.07% of all outstanding shares. On the other hand, iShares Core S&P Smallcap ETF held roughly 10.16 million shares worth around $114.52 million, which represents about 6.59% of the total shares outstanding.